support@dailyagronews.com      +91-8484924178

Morphic Appoints Acceleron’s Peter Linde as Its Chief Medical Officer

Morphic Appoints Acceleron’s Peter Linde as Its Chief Medical Officer
By: biot11 Posted On: March 18, 2020 View: 13

Morphic Appoints Acceleron’s Peter Linde as Its Chief Medical Officer

Xconomy Boston — 

Morphic Therapeutic (NASDAQ: MORF) on Tuesday named Peter Linde as its chief medical officer.

Linde was most recently vice president of medical research at Acceleron Pharma (NASDAQ: XLRN), where he oversaw the design and execution of clinical trials including late-stage development work on luspatercept, a drug the FDA approved last year for patients with the rare blood disorder beta thalassemia. His previous experience includes roles at AbbVie (NYSE: ABBV), FibroGen (NASDAQ: FGEN), and Johnson & Johnson (NYSE: JNJ).

Waltham, MA-based Morphic is developing small molecule drugs that target a class of receptors called integrins. The company anticipates its lead drug candidate—an investigational treatment for inflammatory bowel disease—will enter this clinic this year.

Sarah de Crescenzo is an Xconomy editor based in San Diego. You can reach her at sdecrescenzo@xconomy.com. Follow @sarahdc

Trending on Xconomy

  Contact Us
  Dailyagronews.com.

Botawala Chambers , Fort-Mumbai

Tel : + (91) - 8484924178
Mail : support@dailyagronews.com
Business Hours : 9:30 - 5:30

  About

Dailyagronews is a dedicated platform for Exclusive Agriculture News , Now stay in touch with latest happenings in Agriculture . This site is a work of team of technocrafts wanted to help the farming community by contributing something helpful to them. Join this unique platform by contributing the agro news , we will be happy to make it viral